Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QMix
- Development stage
- Phase 3
- Lead developer
- Dentsply Sirona
- Administration
- Topical
01
Overview
QMix is an endodontic irrigation solution, specifically marketed as "QMix 2-in-1", developed by Dentsply Tulsa, Maillefer, Ballaigues, Switzerland. It is utilized in root canal treatments to facilitate disinfection, remove the smear layer and debris, and promote periapical healing. Clinical trials and in vitro studies have compared its efficacy in these aspects to other common irrigants such as sodium hypochlorite (NaOCl) and ethylenediaminetetraacetic acid (EDTA). QMix has also been evaluated for its impact on the bond strength of adhesively luted glass fiber-reinforced composite posts to root dentin.
- Brand names
- QMix 2-in-1QMix2-in-1QMix-2-in-1
- Other names
- QMix 2in1QMix2in1QMix-2in1
Beyond the preview
Go deeper on QMix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QMix.